- The trend backdrop is active with a 3-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
AKSHARCHEM
NSI
Week ended 07 Aug 2026
Weekly Investor Report
AksharChem (India) Limited · Basic Materials · Specialty Chemicals
Latest close
278.2 INR
11.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 30.5% above the Trend Line and sits at 72.6% of its 52-week range. The latest completed week returned 11.3%, after a 18.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 44/100.
Setup score
62
out of 100
Latest Close
278.2 INR
7 Aug 2026
1W Return
11.3%
latest completed week
4W Return
18.4%
short-term follow-through
12W Return
40.2%
quarterly tape
Trend Breadth
28.8%
15 of 52 weeks active
Volume Ratio
2.7x
vs 13-week average
- Next-week expectancy is negative at 36.31% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
11.3%
Latest completed week; four-week move 18.4%.
Indicator stack
26/74
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.31%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
44/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 30.5% above the Trend Line and sits at 72.6% of its 52-week range. The latest completed week returned 11.3%, after a 18.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5012-week average 0.21
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.50Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 18.4% over four weeks, 40.2% over 12 weeks, and 6.6% over one year. The current trend has remained active for 3 consecutive weeks.
Performance by holding period
Active trend streak3 weeks
Active weeks in one year15
Trend breadth28.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.30Latest activity-pressure read.
Pressure change11.1%Four-week change in activity pressure.
Leadership20.33Latest relative-leadership reading.
RS change942.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength17/100Blend of value, momentum, and quality. Underlying universe rank 84; rank 1 is best.
Value32/100Relative valuation strength. Underlying universe rank 69; rank 1 is best.
Quality6/100Profitability and accounting quality. Underlying universe rank 95; rank 1 is best.
Momentum65/100Medium-term price momentum. Underlying universe rank 36; rank 1 is best.
Growth34/100Revenue and earnings growth. Underlying universe rank 67; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.6x Market value relative to trailing revenue.
- EV / EBITDA
- 17.6x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -10.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 40.1% Gross profit retained from each unit of revenue.
- Operating margin
- 0.1% Operating profit retained from revenue.
- Free-cash-flow margin
- -9.2% Free cash flow generated from revenue.
- Return on invested capital
- 0.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 7.6% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.3% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 5.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment44/100
Weighted news tone is neutral across 11 relevant articles.
1 positive · 8 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.7%Distance below the 52-week high.
13-week volatility8.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2611 weeks finished lower.
Best week+20.0%Week of 19 Jun.
Worst week-17.7%Week of 27 Mar.
Latest week+11.3%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains5
Flat weeks1
Modest losses4
Sharp losses7
Recent vol8.8%13-week weekly-return volatility.
Base vol6.9%52-week weekly-return volatility.
Up/down split26/25Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -4.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank- / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis57/100Latest 12-week confirmation: trend 3/12, activity pressure 12/12, relative leadership 8/12.
Activity pressure 0.50; No reversal markers Next-Week ExpectancyNegative 36.31%Next-week expectancy is negative with a 36.31% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors27/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 20; Buyback Yield rank 22; Small Cap Core rank 43 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment44/100Weighted news tone is neutral across 11 relevant articles.
AksharChem India Ltd. Revenue Breakdown – NSE:AKSHARCHEM Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 278.2 INR | 11.3% | 213.2 INR | 263.4 INR | 1.30 | 20.33 | 58.6K | On |
| 31 Jul 2026 | 249.9 INR | 5.6% | 211.5 INR | 263.1 INR | 1.19 | 9.06 | 19.7K | On |
| 24 Jul 2026 | 236.6 INR | 0.7% | 211.2 INR | 263.1 INR | 1.07 | 5.66 | 11.2K | On |
| 17 Jul 2026 | 235.0 INR | 0.0% | 211.5 INR | 263.1 INR | 1.06 | 1.98 | 7.5K | Off |
| 10 Jul 2026 | 235.0 INR | 1.9% | 212.0 INR | 263.1 INR | 1.17 | 1.95 | 15.4K | Off |
| 3 Jul 2026 | 230.7 INR | -3.7% | 212.4 INR | 263.1 INR | 1.01 | -0.64 | 2.0K | Off |
| 26 Jun 2026 | 239.6 INR | -3.5% | 213.1 INR | 263.2 INR | 0.99 | 3.67 | 0 | Off |
| 19 Jun 2026 | 248.4 INR | 20.0% | 214.0 INR | 263.2 INR | 0.81 | 7.61 | 105.9K | Off |
| 12 Jun 2026 | 207.0 INR | -9.0% | 214.0 INR | 263.1 INR | 0.50 | -8.75 | 2.8K | Off |
| 5 Jun 2026 | 227.5 INR | 19.5% | 215.9 INR | 263.4 INR | 0.45 | 1.14 | 26.3K | Off |
| 29 May 2026 | 190.4 INR | -4.2% | 216.7 INR | 263.4 INR | 0.34 | -16.04 | 11.3K | Off |
| 22 May 2026 | 198.7 INR | 0.1% | 219.3 INR | 263.7 INR | 0.31 | -13.36 | 10.4K | Off |
| 15 May 2026 | 198.5 INR | -4.8% | 221.6 INR | 263.8 INR | 0.19 | -13.57 | 11.3K | Off |
| 8 May 2026 | 208.4 INR | 4.6% | 223.7 INR | 264.0 INR | 0.02 | -11.51 | 18.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.